GO
Loading...

Analyst likes large cap biotechs

Friday, 21 Mar 2014 | 2:06 PM ET

Discussing the market's big reaction to news U.S. lawmakers requested information about Gilead's hepatitis C drug Sovaldi, and which stocks are attractive in the sector, with Geoff Porges, Bernstein Research senior analyst.